Rare diseases
Investigational molecules
Locations
Back to Germany405 clinical trials in Duesseldorf, Germany across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness and Safety of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on the Effectiveness and Safety of JNJ-95475939 and Dupilumab for Treating Moderate to Severe Atopic Dermatitis in Adults
GermanyStudy on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis
GermanyStudy on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3
GermanyStudy on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis
GermanyStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
GermanyStudy on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer
GermanyStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
GermanyStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
GermanyStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
GermanyStudy of GLPG3667 for Adults with Active Systemic Lupus Erythematosus
GermanyStudy of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on colorectal cancer, breast cancer, and esophageal cancer treatments. Studies evaluate novel combination therapies and targeted treatments for various cancer types.
Research includes promising immunotherapy combinations and specialized treatments for different cancer stages.
Comprehensive research on atopic dermatitis, pyoderma gangrenosum, and plaque psoriasis. Studies focus on preventive measures and innovative treatments for chronic skin conditions.
Emphasis on both preventive care and treatment of severe skin manifestations.
Studies examining treatments for multiple sclerosis, uveitis, and graft-versus-host disease. Research aims to develop targeted therapies for complex autoimmune conditions.
Focus on improving patient outcomes through novel therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
